ROM InWest Invests €1.5 million into AI and Computer Vision Company Kepler Vision Technologies

Summation

  • This solution technology outperforms motion sensors, bed mats, and wearable monitoring systems by a factor of 1,000 in cutting down on false alarms, and the unnecessary strain they place on care staff.
  • A quarter of the current workforce will retire in the next five years, while the number of elderly people will continue to grow.
  • Thanks to the investment from ROM InWest, we can scale up our Kepler Night Nurse production to help more healthcare professionals in their work.

ROM InWest Invests

Kepler Vision Technologies, a software developer in the healthcare sector, has received an investment of €1.5 million from Dutch investment company ROM InWest. With the investment, the health-technology company will scale up the production of their Kepler Night Nurse. This smart sensor technology, applicable in elderly care among others, helps reduce the workload for healthcare professionals while simultaneously improving the quality of care.

Kepler Vision’s Night Nurse

Kepler Vision’s Night Nurse solution is a computer vision-based body language detection system. By combining AI and computer vision, Kepler Night Nurse is able to detect falls, patient discomfort and abnormal behaviour, notifying care staff so that they can respond immediately. The company has also recently added a new lying position detection feature that identifies the potential of pressure ulcers. This solution technology outperforms motion sensors, bed mats, and wearable monitoring systems by a factor of 1,000 in cutting down on false alarms, and the unnecessary strain they place on care staff.

International Distribution

The Night Nurse product has already been distributed internationally across 8 European countries through 26 different partners in care homes and hospitals. With the investment from ROM InWest, the company will look to widen its reach with plans of entering the UK and US market already in motion.

Harro Stokman, CEO of Kepler Vision Technologies says:

“The healthcare sector has been facing urgent staff shortages for years. This problem is only getting worse due to an aging population. A quarter of the current workforce will retire in the next five years, while the number of elderly people will continue to grow. Elderly care therefore needs more support than ever. Thanks to the investment from ROM InWest, we can scale up our Kepler Night Nurse production to help more healthcare professionals in their work. My goal is for our software to be accessible across the world, and with great support like this, we get closer to achieving this”.

Janet Nieboer, CEO of ROM InWest comments:

“We are proud to contribute to Kepler’s healthcare solution. The Kepler Night Nurse offers a smart and more reliable alternative to existing home automation systems. It contributes to good patient care and makes the work of healthcare professionals more efficient. Smart healthcare solutions like these are essential to maintain the quality and affordability of our healthcare.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology

The funding will accelerate candidate selection for preclinical studies and develop a pipeline of protein-based therapeutics. The primary focus for the pipeline will be recombinant proteins that have historically faced production and manufacturing challenges based on current technology notes ExpressionEdits.

Matter Bio Successfully Closes $7M Seed Funding Round

"Genomic integrity is a cornerstone of longevity and healthspan extension," said George Church, Professor of Genetics at Harvard Medical School. "Matter Bio is pioneering a crucial approach in the fight against aging by focusing on the preservation of our genetic blueprint. I am excited to see the impact of their work on enhancing human health."

Enifer Secures €36M In Funding

Enifer, a biotech scaleup is gearing up the production of its PEKILO® mycoprotein with a new €33M factory located in Kirkkonummi, Finland. With already existing collaborations with the world’s leading food and feed companies, Enifer is prepared to annually upcycle food industry side streams into up to 3,000 tons of its sustainable fungi-based protein

By using this website you agree to accept Medical Device News Magazine Privacy Policy